News
Fintel on MSN21h
Barclays Upgrades Sarepta Therapeutics (SRPT)Fintel reports that on July 29, 2025, Barclays upgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from ...
Fintel on MSN21h
Bernstein Initiates Coverage of Sarepta Therapeutics (SRPT) with Market Perform RecommendationFintel reports that on July 29, 2025, Bernstein initiated coverage of Sarepta Therapeutics (NasdaqGS:SRPT) with a Market Perform recommendation. Analyst Price Forecast Suggests 214.51% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback